Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) today announced a significant expansion of its manufacturing capacity through a ...

Breakthrough research could make any IV drug able to be taken orally for a range of hard-to-treat cancers and other diseases, and redefine how medicines are designed, evaluated and delivered.

PursueCare to Spotlight Next-Gen Digital Therapeutics at the 56th American Society of Addiction Medicine (ASAM) Conference in ...

In the end, AI-driven digital legacies are about preserving what makes us human. For critically ill patients, it’s a way to ...

The U.S. digital therapeutics market size was valued at $1.16 billion in 2019 and is expected to reach $5.08 billion by 2027 with a CAGR of 19.2% during the forecast period. Increase in adoption of ...